Marinomed Biotech AG (MARI.VI)
EUR 15.9
(0.32%)
EUR 15.9
(0.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.18 Million | 11.27 Million | 11.62 Million | 8.12 Million | 6.14 Million | 4.66 Million |
| Cost of Revenue | 13.76 Million | 9.13 Million | 10.2 Million | 8.76 Million | 6.65 Million | 4.83 Million |
| Gross Profit | -4.58 Million | 2.14 Million | 1.42 Million | -641.7 Thousand | -512.3 Thousand | -165.44 Thousand |
| Operating Expenses | 1.91 Million | 7.01 Million | 5.56 Million | 5.22 Million | 5.77 Million | 4.99 Million |
| Selling, General and Administrative Expenses | 1.26 Million | 1.69 Million | 1.45 Million | 1.36 Million | 1.33 Million | 2.39 Million |
| Research and Development Expenses | 7.03 Million | 6.9 Million | 7.5 Million | 5.94 Million | 4.77 Million | 2.93 Million |
| Other Expenses | 5 Million | - | - | -2400.00 | -1200.00 | 8157.30 |
| Cost and Expenses | 14.31 Million | 16.14 Million | 15.77 Million | 13.98 Million | 12.43 Million | 9.82 Million |
| Operating Income | -5.12 Million | -4.91 Million | -4.14 Million | -5.81 Million | -6.21 Million | -5.14 Million |
| Interest Expense | 2.48 Million | 2.5 Million | 1.5 Million | 713.6 Thousand | 665.4 Thousand | 2.99 Million |
| Income Tax Expense | 4000.00 | 6800.00 | 197.1 Thousand | 3500.00 | 4400.00 | 3500.00 |
| Earnings before Tax | -6.79 Million | -6.39 Million | -5.69 Million | -6 Million | -7.21 Million | -12.09 Million |
| Net Income | -6.79 Million | -6.39 Million | -5.89 Million | -6.01 Million | -7.21 Million | -12.09 Million |
| Earnings Per Share Basic | -4.48 | -4.27 | -3.99 | -4.09 | -5.09 | -12.10 |
| Earnings Per Share Diluted | -4.48 | -4.27 | -3.99 | -4.09 | -5.09 | -12.10 |
| Weighted Average Shares Outstanding | 1.51 Million | 1.49 Million | 1.47 Million | 1.47 Million | 1.41 Million | 1 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.51 Million | 1.49 Million | 1.47 Million | 1.47 Million | 1.41 Million | 1 Million |
| Gross Margin | -0.50 | 0.19 | 0.12 | -0.08 | -0.08 | -0.04 |
| EBIT Margin | -0.39 | -0.28 | -0.31 | -0.60 | -0.96 | -0.69 |
| Profit Margin | -0.74 | -0.57 | -0.51 | -0.74 | -1.17 | -2.59 |
| EBITDA | -3.62 Million | -3.21 Million | -3.57 Million | -4.86 Million | -6.21 Million | -10.36 Million |
| Earnings Before Tax Margin | -0.56 | -0.44 | -0.36 | -0.72 | -1.01 | -1.10 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 737.5 Thousand | 9.18 Million | 2.02 Million | 1.92 Million | 1.9 Million | 3.31 Million |
| Cost of Revenue | 2.24 Million | 13.76 Million | 3.21 Million | 1.79 Million | 1.57 Million | 2.87 Million |
| Gross Profit | -1.5 Million | -4.58 Million | -1.18 Million | 136.5 Thousand | 337.1 Thousand | 440.6 Thousand |
| Operating Expenses | 370.4 Thousand | 1.91 Million | -458.3 Thousand | 1.63 Million | 2.05 Million | 1.93 Million |
| Selling, General and Administrative Expenses | -1.19 Million | - | -1.14 Million | -1.28 Million | -1.23 Million | -1.44 Million |
| Research and Development Expenses | 1.58 Million | - | 1.71 Million | 1.6 Million | 1.77 Million | 1.93 Million |
| Other Expenses | 22.1 Thousand | - | 1.03 Million | 36.4 Thousand | 199.9 Thousand | 102.2 Thousand |
| Cost and Expenses | 2.61 Million | 15.68 Million | 2.75 Million | 3.42 Million | 3.62 Million | 4.81 Million |
| Operating Income | -1.87 Million | -6.5 Million | -729.3 Thousand | -1.49 Million | -1.51 Million | -1.39 Million |
| Interest Expense | 664 Thousand | 2.48 Million | 606 Thousand | 597.3 Thousand | 618.8 Thousand | 667.8 Thousand |
| Income Tax Expense | 1000.00 | 4000.00 | 1000.00 | 1000.00 | 1000.00 | 1000.00 |
| Earnings before Tax | -2.12 Million | -6.79 Million | -1.19 Million | -2.09 Million | -1.45 Million | -2.05 Million |
| Net Income | -2.13 Million | -6.79 Million | -1.19 Million | -2.09 Million | -1.45 Million | -2.05 Million |
| Earnings Per Share Basic | -1.39 | - | -0.78 | -1.38 | -0.96 | -1.37 |
| Earnings Per Share Diluted | -1.39 | - | -0.78 | -1.38 | -0.96 | -1.37 |
| Weighted Average Shares Outstanding | 1.53 Million | 1.51 Million | 1.52 Million | 1.51 Million | 1.51 Million | 1.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.53 Million | 1.51 Million | 1.52 Million | 1.51 Million | 1.51 Million | 1.5 Million |
| Gross Margin | -2.04 | -0.50 | -0.59 | 0.07 | 0.18 | 0.13 |
| EBIT Margin | -2.32 | - | -0.28 | -0.69 | -0.81 | -0.37 |
| Profit Margin | -2.89 | -0.74 | -0.59 | -1.09 | -0.76 | -0.62 |
| EBITDA | -1.71 Million | - | -563.4 Thousand | -1.32 Million | -1.53 Million | -1.22 Million |
| Earnings Before Tax Margin | -2.55 | -0.71 | -0.36 | -0.77 | -0.79 | -0.42 |
8367
BLKASHYAP
8091
4441
ORINF
USREF